Acute Psychiatric Management of Suicidal Ideation in Borderline Personality Disorder

Immediate Risk Assessment and Disposition

The American Academy of Pediatrics recommends assessing suicide risk by evaluating factors such as frequency and intensity of suicidal thoughts, access to lethal means, and history of previous suicide attempts 1
A structured suicide risk assessment should focus on current psychiatric symptoms, social support availability, and recent stressors, with hospitalization considered for patients expressing a desire to die or lacking adequate support 2
The assessment should also consider comorbid substance abuse and high levels of anger or impulsivity as additional risk factors 1

A collaborative crisis response plan should include identification of clear warning signs and triggers for suicidal ideation recurrence, as well as specific coping strategies and healthy distraction activities 1, 3
The plan should also involve restricting access to lethal means, such as firearms, medications, and knives, and providing professional support contact information and instructions for reaccessing emergency services 1, 3

Counseling patients and families about restricting access to potentially lethal means is crucial, as 24% of suicide attempts occur within 0-5 minutes of the decision, making impulsivity a critical factor 1, 2
Specific interventions include removing firearms from the home, locking up medications, and restricting alcohol access 1, 2

The American College of Physicians recommends initiating dialectical behavior therapy (DBT) as the evidence-based treatment specifically developed for borderline personality disorder with suicidal behavior 4, 3
DBT combines cognitive-behavioral therapy elements, skills training, and mindfulness techniques to develop emotion regulation skills, interpersonal effectiveness, and distress tolerance 4, 3
Evidence shows DBT reduces both suicidal ideation and repetition of self-directed violence in patients with BPD compared to treatment as usual 4, 3

The American Psychiatric Association notes that there is no evidence that any psychoactive medication consistently improves core symptoms of borderline personality disorder 5
For comorbid major depression, consider SSRIs (escitalopram, sertraline, or fluoxetine) over other antidepressants due to better safety profile, and avoid tricyclic antidepressants due to high lethality in overdose 5
For severe, treatment-resistant suicidal ideation with comorbid major depression, consider ketamine infusion (0.5 mg/kg single dose) for rapid short-term reduction, with benefits beginning within 24 hours and lasting up to one week 3, 5

Schedule definite, closely spaced follow-up appointments and contact the patient if appointments are missed, as the greatest risk of reattempting suicide occurs in the months after an initial attempt 5, 1
Send periodic caring communications (postal mail or text messages) for 12 months following any hospitalization or crisis, as this may reduce suicide attempts 5, 2, 6

The VA/DoD guidelines support ketamine infusion (0.5 mg/kg single dose IV over 40 minutes) as adjunctive treatment for short-term reduction in suicidal ideation in patients with major depressive disorder and suicidal ideation, with benefits beginning within 24 hours and lasting up to one week, requiring 2-hour post-treatment monitoring 7
Clozapine should not be used for reducing recurrent suicidal behavior in borderline personality disorder, as its indication is based on schizophrenia/schizoaffective disorder data, and it has not been shown to decrease suicidal ideation in the acute setting 8